Advances in immuno-oncology biomarkers for gastroesophageal cancer: Programmed death ligand 1, microsatellite instability, and beyond

Blockade of the programmed death ligand 1 (PD-L1) and programmed cell death 1 (PD-1) receptor axis represents an effective form of cancer immunotherapy. Preclinical evidence initially suggested that gastric and gastroesophageal junction (GEJ) cancers are potentially immunotherapy-sensitive tumors. E...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Emily M, Gong, Jun, Klempner, Samuel J, Chao, Joseph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2018
Materias:
Minireviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6034145/
https://www.ncbi.nlm.nih.gov/pubmed/29991874
http://dx.doi.org/10.3748/wjg.v24.i25.2686

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6034145/
https://www.ncbi.nlm.nih.gov/pubmed/29991874
http://dx.doi.org/10.3748/wjg.v24.i25.2686

Ejemplares similares